Transactions
Anaheim Clinical Trials acquired by CenExel Clinical Research
Feb. 2019
Client: Anaheim Clinical Trials is a Phase I – IV clinical research site
Role: Edgemont Partners acted as exclusive financial advisor to Anaheim Clinical Trials in its sale to CenExel Clinical Research
Location: Anaheim, CA
Sector: Pharmaceutical Services
Lead Banker: David Blume